Amit Malhotra: The Expanding Role of Upadacitinib Across Autoimmune and Inflammatory Disorders
Amit Malhotra, Chairman of Headquarters Committee at IADVL, shared a post on LinkedIn:
“Had the privilege of attending a highly informative CME on Upadacitinib at Dehradun.
The scientific discussions highlighted how JAK-STAT inhibitors are transforming the management of several chronic inflammatory and autoimmune disorders.
Upadacitinib works by selectively inhibiting Janus Kinase (JAK) pathways, thereby blocking inflammatory signals transmitted through the JAK-STAT pathway.
This targeted mechanism helps reduce inflammation, itching, pain, and tissue damage while improving patient outcomes.
The molecule has demonstrated impressive efficacy in conditions such as Atopic Dermatitis, Alopecia Areata, Vitiligo, Psoriatic Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, and Ulcerative Colitis.
With rapid onset of action and sustained disease control, JAK inhibitors represent a significant advancement in precision medicine.
Grateful to the organizers and faculty for an enriching academic experience and valuable clinical insights.
Caution: Do not self medicate.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 13:10Scott Cameron: Olfactory Receptor Signaling as a Druggable Target in Cardiovascular Disease
-
Jun 23, 2026, 12:52Zain Khalpey: Understanding the Mechanisms of Sudden Cardiac Death
-
Jun 23, 2026, 12:43Victoria Azodoh: Strengthening Maternal Nutrition Through Evidence-Based Action
-
Jun 23, 2026, 12:37Sophia Delicou: Featured on the Cover of the British Journal of Haematology
-
Jun 23, 2026, 12:29Mattia Liverani։ AHA Highlights New Approaches in Iron Deficiency Management
-
Jun 23, 2026, 12:19Maha Sallam: What Baseline Hemoglobin Reveals About SCA
-
Jun 23, 2026, 11:05Vicky Williams: The Impact of the Stroke Same Day Emergency Care Model on The Outcomes
-
Jun 23, 2026, 10:54Rucha Patil: Honored to Be Appointed to the State-Level Committee on Haemophilia in Maharashtra
-
Jun 23, 2026, 10:48Shamee Shastry: Lewis Antigen Elution and the Challenge of False-Negative Reactions